Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Assessment of Hyperammonemia Risk Sodium Valproate Injection in Perioperative Neurosurgery Patients
*Corresponding Author: Braun Herton, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, U.S.A, Email: b.herton25@jhmi.eduReceived Date: May 01, 2024 / Published Date: May 30, 2024
Citation: Braun H (2024) Assessment of Hyperammonemia Risk Sodium ValproateInjection in Perioperative Neurosurgery Patients. Neurol Clin Therapeut J 8: 207.
Copyright: © 2024 Braun H. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Abstract
This study investigates the clinical impact of perioperative sodium valproate injection on Hyperammonemia in neurosurgery patients. Hyperammonemia is a known complication in neurosurgery, particularly in patients receiving sodium valproate due to its potential to disrupt ammonia metabolism. The introduction of this study highlights the significance of Hyperammonemia in neurosurgical settings and the need for effective management strategies. The results section presents the findings of the clinical analysis, including the incidence of Hyperammonemia, the effect of sodium valproate injection on ammonia levels, and any associated complications. Finally, the conclusion summarizes the implications of the study findings, discussing the efficacy and safety of perioperative sodium valproate injection in mitigating Hyperammonemia in neurosurgery patients and providing recommendations for clinical practice.
